{"id":62596,"date":"2026-02-04T19:05:59","date_gmt":"2026-02-04T18:05:59","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\/"},"modified":"2026-02-04T19:05:59","modified_gmt":"2026-02-04T18:05:59","slug":"federal-court-grants-whoop-preliminary-injunction-against-lexqi","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\/","title":{"rendered":"Federal Court Grants WHOOP Preliminary Injunction Against Lexqi"},"content":{"rendered":"
\n

\nInjunction orders Lexqi to halt U.S. Sales of wearable health tracker<\/i><\/p>\n

BOSTON–(BUSINESS WIRE)–WHOOP,<\/a> the human performance company, today announced that the U.S. District Court for the District of Massachusetts has granted a motion by WHOOP for a preliminary injunction against Shenzhen Lexqi Electronic Technology Co., Ltd. (Lexqi). The injunction, issued in a trade dress infringement lawsuit brought by WHOOP, orders Lexqi to immediately stop selling its infringing wearable product in the United States while the litigation proceeds.<\/p>\n

<\/a>
<\/a>
<\/a>
<\/a><\/p>\n

\nWHOOP filed the lawsuit to protect the iconic design of its wearable, described as \u201ca continuous fabric band that wraps over the device (i.e. a faceless device) with thin metal accents on the side of the device.\u201d In its ruling, the court said, referring to this distinctive design, that \u201c[t]he Whoop Trade Dress has been employed by plaintiff for more than ten years, and it has been central to plaintiff\u2019s entire business during that timeframe.\u201d The court found that the Lexqi device \u201cis almost identical to [the WHOOP] device that embodies the WHOOP Trade Dress.\u201d Therefore, WHOOP demonstrated a likelihood of success on the merits of its trade dress infringement claim and that continued sales of Lexqi\u2019s product were likely to cause consumer confusion and irreparable harm absent immediate relief.<\/p>\n

\n\u201cWHOOP members trust us with their data and rely on our technology to make meaningful decisions about their health and performance,\u201d said Jason Lynch, Chief Administrative Officer and Chief Legal Officer of WHOOP. \u201cProtecting our intellectual property is essential to preserving that trust. This ruling reinforces our commitment to innovation on behalf of our members and affirms the importance of respecting original technology.\u201d<\/p>\n

\nWHOOP filed suit against Lexqi in September 2025, asserting claims under the Lanham Act and related laws. The federal court\u2019s decision reflects the importance of protecting consumers from confusion in the marketplace and ensuring that companies compete through genuine innovation rather than imitation.<\/p>\n

\nWHOOP will continue to defend its intellectual property to safeguard the authenticity, quality, and integrity of the WHOOP experience as the case moves forward. The litigation is captioned WHOOP, Inc. v. Shenzhen Lexqi Electronic Technology Co., Ltd.<\/i>, Case No. 25-12690-FSS (D. Mass.). WHOOP is represented by Josh Dalton, Katherine Soule, and Tessa Ruff of Morgan, Lewis & Bockius.<\/p>\n

\nAbout WHOOP<\/b>:<\/p>\n

\nWHOOP, the human performance company, empowers people to unlock their potential and live longer, healthier lives. The WHOOP membership delivers world-class wearable technology, personalized coaching, and actionable insights across recovery, sleep, training, and health.<\/p>\n

\nWHOOP wearable devices feature groundbreaking innovations such as cardiovascular health screening (including an FDA-cleared ECG), Healthspan to measure Pace of Aging and WHOOP Age, and the first-of-its-kind wearable Blood Pressure Insights.<\/p>\n

\nFounded in 2012 and headquartered in Boston, WHOOP has raised more than $400 million in venture capital and ships to 56 markets worldwide. To learn more or start a one-month free trial, visit whoop.com<\/a> and connect with WHOOP on Instagram<\/a>, X<\/a>, Facebook<\/a>, LinkedIn<\/a>, and YouTube<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nTaylor Georgeson
\n
whoop@jacktaylorpr.com<\/a>
Jack Taylor Worldwide<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Injunction orders Lexqi to halt U.S. Sales of wearable health tracker BOSTON–(BUSINESS WIRE)–WHOOP, the human performance company, today announced that the U.S. District Court for the District of Massachusetts has granted a motion by WHOOP for a preliminary injunction against Shenzhen Lexqi Electronic Technology Co., Ltd. (Lexqi). The injunction, issued in a trade dress infringement … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62596","6":"format-standard","7":"category-industry"},"yoast_head":"\nFederal Court Grants WHOOP Preliminary Injunction Against Lexqi - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Federal Court Grants WHOOP Preliminary Injunction Against Lexqi - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Injunction orders Lexqi to halt U.S. Sales of wearable health tracker BOSTON–(BUSINESS WIRE)–WHOOP, the human performance company, today announced that the U.S. District Court for the District of Massachusetts has granted a motion by WHOOP for a preliminary injunction against Shenzhen Lexqi Electronic Technology Co., Ltd. (Lexqi). The injunction, issued in a trade dress infringement ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-04T18:05:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260204015721\/en\/2711588\/22\/SuperKnit_Luxe_MG_Pack_-_Dune-Gold%2C_Obsidian-Gold%2C_Midnight-Titanium_%281%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Federal Court Grants WHOOP Preliminary Injunction Against Lexqi\",\"datePublished\":\"2026-02-04T18:05:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\\\/\"},\"wordCount\":507,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260204015721\\\/en\\\/2711588\\\/22\\\/SuperKnit_Luxe_MG_Pack_-_Dune-Gold%2C_Obsidian-Gold%2C_Midnight-Titanium_%281%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\\\/\",\"name\":\"Federal Court Grants WHOOP Preliminary Injunction Against Lexqi - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260204015721\\\/en\\\/2711588\\\/22\\\/SuperKnit_Luxe_MG_Pack_-_Dune-Gold%2C_Obsidian-Gold%2C_Midnight-Titanium_%281%29.jpg\",\"datePublished\":\"2026-02-04T18:05:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260204015721\\\/en\\\/2711588\\\/22\\\/SuperKnit_Luxe_MG_Pack_-_Dune-Gold%2C_Obsidian-Gold%2C_Midnight-Titanium_%281%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260204015721\\\/en\\\/2711588\\\/22\\\/SuperKnit_Luxe_MG_Pack_-_Dune-Gold%2C_Obsidian-Gold%2C_Midnight-Titanium_%281%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Federal Court Grants WHOOP Preliminary Injunction Against Lexqi\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Federal Court Grants WHOOP Preliminary Injunction Against Lexqi - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\/","og_locale":"en_US","og_type":"article","og_title":"Federal Court Grants WHOOP Preliminary Injunction Against Lexqi - Pharma Trend","og_description":"Injunction orders Lexqi to halt U.S. Sales of wearable health tracker BOSTON–(BUSINESS WIRE)–WHOOP, the human performance company, today announced that the U.S. District Court for the District of Massachusetts has granted a motion by WHOOP for a preliminary injunction against Shenzhen Lexqi Electronic Technology Co., Ltd. (Lexqi). The injunction, issued in a trade dress infringement ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\/","og_site_name":"Pharma Trend","article_published_time":"2026-02-04T18:05:59+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260204015721\/en\/2711588\/22\/SuperKnit_Luxe_MG_Pack_-_Dune-Gold%2C_Obsidian-Gold%2C_Midnight-Titanium_%281%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Federal Court Grants WHOOP Preliminary Injunction Against Lexqi","datePublished":"2026-02-04T18:05:59+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\/"},"wordCount":507,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260204015721\/en\/2711588\/22\/SuperKnit_Luxe_MG_Pack_-_Dune-Gold%2C_Obsidian-Gold%2C_Midnight-Titanium_%281%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\/","url":"https:\/\/pharma-trend.com\/en\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\/","name":"Federal Court Grants WHOOP Preliminary Injunction Against Lexqi - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260204015721\/en\/2711588\/22\/SuperKnit_Luxe_MG_Pack_-_Dune-Gold%2C_Obsidian-Gold%2C_Midnight-Titanium_%281%29.jpg","datePublished":"2026-02-04T18:05:59+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260204015721\/en\/2711588\/22\/SuperKnit_Luxe_MG_Pack_-_Dune-Gold%2C_Obsidian-Gold%2C_Midnight-Titanium_%281%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260204015721\/en\/2711588\/22\/SuperKnit_Luxe_MG_Pack_-_Dune-Gold%2C_Obsidian-Gold%2C_Midnight-Titanium_%281%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/federal-court-grants-whoop-preliminary-injunction-against-lexqi\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Federal Court Grants WHOOP Preliminary Injunction Against Lexqi"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62596","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62596"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62596\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62596"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62596"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62596"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}